The economic, social and health impact of the pandemic has underscored the strategic importance of a strong global biotechnology industry. The international community has been made aware of how connected the world is regarding scientific discovery, innovation, supply chain, manufacturing, and entrepreneurship as the biotech industry brought forward highly effective vaccines.
This discussion highlights the growth and economic opportunity the biotechnology industry has achieved in recent years and how to take the lessons learned from the pandemic experience and apply them to other challenges including our changing climate.
Dr. Michelle McMurry-Heath | President and CEO, BIO
Dr. Claire Skentelbery | Director General, EuropaBio
Andrew Casey | President and CEO, BIOTECanada